Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/01/1997 | US5643766 Synthesis of full-length, double-stranded DNA from a single-stranded linear DNA template |
07/01/1997 | US5643765 Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction |
07/01/1997 | US5643763 Method for making recombinant yeast artificial chromosomes by minimizing diploid doubling during mating |
07/01/1997 | US5643762 Method for synthesizing single-stranded stem-loop DNAs, the products and uses therefor |
07/01/1997 | US5643761 Cells with dna, releasing, denaturing and hybridizing dna inserts |
07/01/1997 | US5643759 Hybridoma cell lines |
07/01/1997 | US5643758 Production and purification of a protein fused to a binding protein |
07/01/1997 | US5643756 Fusion glycoproteins |
07/01/1997 | US5643754 Nucleic acids encoding a leptospira outer membrane protein |
07/01/1997 | US5643753 Use of autologous promoters to express gene products in bordetella |
07/01/1997 | US5643750 Human neuronal beta subunits of voltage-operated calcium channels and the use thereof |
07/01/1997 | US5643749 Soluble interferon α-receptor, its preparation and use |
07/01/1997 | US5643748 HU-B1.219, a novel human hematopoietin receptor |
07/01/1997 | US5643747 Gene expression and cloning of bordetella genome and dna sequences |
07/01/1997 | US5643746 Human epidermal gene promoter |
07/01/1997 | US5643745 Heterologous dimeric proteins produced in heterokaryons |
07/01/1997 | US5643736 Hybridomas and detection of osteogenic cell subsets |
07/01/1997 | US5643735 Anti-thymosin α1 monoclonal antibody-producing hybridoma |
07/01/1997 | US5643734 Kits for qualitative and quantitative analysis |
07/01/1997 | US5643730 Diagnostic screening, lysis, amplification, hybridization |
07/01/1997 | US5643729 Methods for diagnosing cancer, precancerous state, or susceptibility to other forms of diseases by detecting an acceleration of exon skipping in IRF-1 mRNA |
07/01/1997 | US5643727 BCL-2 gene inhibitory element binding factor |
07/01/1997 | US5643726 Integral membrane glycoproteins, genes and promoters |
07/01/1997 | US5643720 Method of inhibiting transcription utilizing nuclear receptors |
07/01/1997 | US5643719 B-carotene |
07/01/1997 | US5643718 Expression of chloramphenicol acetyl transferase, toxoplasma |
07/01/1997 | US5643717 Capillary electrophoresis, linear polymer and denaturing solvent |
07/01/1997 | US5643715 Human papillomavirus type 52 DNA sequences and methods for employing the same |
07/01/1997 | US5643714 Method and assay for HTLV |
07/01/1997 | US5643578 Subunit vaccines |
07/01/1997 | US5643576 Method of inducing an immune response with a live Venezuelan Equine Encephalitis virus expressing a heterologous immunogen |
07/01/1997 | US5643570 BPI-immunoglobulin fusion proteins |
07/01/1997 | US5643567 Antigrowth agents for tumors |
07/01/1997 | US5643563 N-∇3 deletion mutants of the short form of CSF-1 |
06/26/1997 | WO1997022972A2 Method for the simultaneous detection of a therapeutic target for a disease state and its neutralizing antibody-like molecule |
06/26/1997 | WO1997022722A1 Genetic suppressor elements against human immunodeficiency virus |
06/26/1997 | WO1997022719A1 Method for nucleic acid analysis using fluorescence resonance energy transfer |
06/26/1997 | WO1997022718A1 Homogeneous dna probe titration assay |
06/26/1997 | WO1997022717A1 Screening method |
06/26/1997 | WO1997022716A1 Process for activating a kinase |
06/26/1997 | WO1997022711A1 Metabolic engineering of polyhydroxyalkanoate monomer synthases |
06/26/1997 | WO1997022709A1 Host adaptation of retroviral vectors |
06/26/1997 | WO1997022707A1 An expression system for anaerobic gene expression in higher plants |
06/26/1997 | WO1997022706A1 Vector for expression of n-terminally extended proteins in yeast cell |
06/26/1997 | WO1997022705A1 A FUNGUNS WHEREIN THE areA, pepC AND/OR pepE GENES HAVE BEEN INACTIVATED |
06/26/1997 | WO1997022704A1 Mitogen-activated protein kinase kinase mek6 and methods of use therefor |
06/26/1997 | WO1997022703A2 Novel starches via modification of expression of starch biosynthetic enzyme genes |
06/26/1997 | WO1997022702A1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
06/26/1997 | WO1997022701A1 Equine rhinovirus 1 proteins |
06/26/1997 | WO1997022700A2 Grapevine leafroll virus proteins and their uses |
06/26/1997 | WO1997022699A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
06/26/1997 | WO1997022698A2 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
06/26/1997 | WO1997022697A1 TGFβ SIGNAL TRANSDUCTION PROTEINS, GENES, AND USES RELATED THERETO |
06/26/1997 | WO1997022696A1 Utrophin gene expression |
06/26/1997 | WO1997022695A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
06/26/1997 | WO1997022694A2 Diagnostic reagents relating to diabetes |
06/26/1997 | WO1997022690A2 SIGNALING INOSITOL POLYPHOSPHATE 5-PHOSPHATASES (SIPs) |
06/26/1997 | WO1997022688A1 Heterophil-adapted poultry vaccine |
06/26/1997 | WO1997022687A1 Improved neurospora hosts for the production of recombinant proteins, and methods for producing the same |
06/26/1997 | WO1997022686A1 Fungal food |
06/26/1997 | WO1997022648A1 Method for reducing the surface reactivity of copolymers produced by electrochemical polymerisation |
06/26/1997 | WO1997022625A1 Ghrh-rp compositions and methods |
06/26/1997 | WO1997022623A1 Osteo antiviral protein |
06/26/1997 | WO1997022617A1 Methods for identifying compounds that bind to a target |
06/26/1997 | WO1997022364A1 FCε-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
06/26/1997 | WO1997022363A2 Improved pharmaceutical compositions |
06/26/1997 | WO1997022250A1 Therapeutic molecules generated by trans-splicing |
06/26/1997 | WO1997022242A1 Mold-resistant plant and process for producing the same |
06/26/1997 | WO1997020045A3 P2u2 purinergic receptor |
06/26/1997 | WO1997013845A3 Phosphopantetheinyl transferases and uses thereof |
06/26/1997 | WO1997011190A3 Dna construct comprising a muscle specific regulatory element for immunization or gene therapy |
06/26/1997 | WO1997007225A3 High efficiency retroviral packaging system |
06/26/1997 | DE19608753C1 Transduction system based on rep-negative adeno-associated virus vector |
06/26/1997 | DE19548476A1 Zielgerichtete Verbindungen mit knorpel- und/oder knocheninduzierender Aktivität Targeted compounds with cartilage and / or osteoinductive activity |
06/26/1997 | DE19548222A1 Verfahren zur mikrobiellen Herstellung von Aminosäuren durch gesteigerte Aktivität von Exportcarriern Process for the microbial production of amino acids by increased activity of export carriers |
06/26/1997 | DE19548122A1 Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
06/26/1997 | DE19547933A1 Multimere Formen von IL-16, Verfahren zu ihrer Herstellung und Verwendung Multimeric forms of IL-16, process for their preparation and use |
06/26/1997 | DE19547733A1 Nucleic acid encoding enzyme involved in starch synthesis and modification |
06/26/1997 | DE19547416A1 New monoclonal antibodies specific for proteosomes |
06/26/1997 | DE19547324A1 cDNA encoding human mucin 8 |
06/26/1997 | CA2246299A1 An expression system for anaerobic gene expression in higher plants |
06/26/1997 | CA2242402A1 Grapevine leafroll virus proteins and their uses |
06/26/1997 | CA2241371A1 Genetic suppressor elements against human immunodeficiency virus |
06/26/1997 | CA2241040A1 Improved pharmaceutical compositions |
06/26/1997 | CA2240938A1 Utrophin gene expression |
06/26/1997 | CA2240667A1 Method for nucleic acid analysis using fluorescence resonance energy transfer |
06/26/1997 | CA2240593A1 Fungal food |
06/26/1997 | CA2240449A1 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
06/26/1997 | CA2240386A1 Mold-resistant plant and process for producing the same |
06/26/1997 | CA2240360A1 Metabolic engineering of polyhydroxyalkanoate monomer synthases |
06/26/1997 | CA2239807A1 Method for reducing the surface reactivity of copolymers produced by electrochemical polymerisation |
06/26/1997 | CA2239783A1 Host adaptation of retroviral vectors |
06/26/1997 | CA2239126A1 Tgf.beta. signal transduction proteins, genes, and uses related thereto |
06/26/1997 | CA2238995A1 Methods for identifying compounds that bind to a target |
06/26/1997 | CA2238961A1 Homogeneous dna probe titration assay |
06/25/1997 | EP0780479A2 Method for quantitative determination of specific nucleic acid sequences |
06/25/1997 | EP0780475A1 CDNA corresponding to the genome of negative-strand RNA viruses, and process for the production of infectious negative-strand RNA viruses |
06/25/1997 | EP0780473A2 Thermostable mutants of D-N-alpha-Carbamoylase |
06/25/1997 | EP0780472A2 Stress proteins |
06/25/1997 | EP0780471A2 Novel nitrilase gene |